Arcitumomab - CEA-Scan; carcinoembryonic antigen monoclonal antibody Fab' fragment--Technetium-99m radioimmune conjugate; IMMU-4 Fab'--Tc 99m -- Product Record

CEA Mab Fab'-Tc 99m radioconj.

    Nomenclature:
      CEA Mab Fab' radioconj. [BIO]
      CEA-Scan [TR]
      arcitumomab [FDA USAN INN]
      Immunoglobulin G 1 (mouse monoclonal IMMU-4 Fab' fragment gamma-chain anti-human antigen CEA), disulfide with mouse monoclonal IMMU-4 light chain, technetium-99mTc salt [CAS for radiolabeled arcitumomab]
      Immunoglobulin G 1 (mouse monoclonal IMMU-4 Fab' fragment gamma-chain anti-human antigen CEA), disulfide with mouse monoclonal IMMU-4 light chain [CAS for arcitumomab]
      154361-48-5 [CAS RN]
      154361-49-6 [CAS RN]
      Anti-Carcinoembryonic Antigen Mab radioconjugate [SY]
      carcinoembryonic antigen monoclonal antibody Fab' fragment--Technetium-99m radioimmune conjugate [SY for arcitumomab]
      F(ab').sub.2-SH fragment [SY for arcitumomab]
      Fab'-SH [SY for arcitumomab]
      IMMU-4 Fab' [SY]
      ImmuRAID-CEA-Tc-99m [SY]
      ImmuRAID-Tc-99m [SY]
      NP-4 [SY original name of IMMU-4 cell line]
      technetium Tc99m arcitumomab [SY]

    FDA Class:  Biologic PLA

    Year of approval (FDA) = 1996

Index Terms: